论文部分内容阅读
随着B型利钠尿肽在指导心力衰竭的诊断、治疗及预后;评估二尖瓣狭窄、房室间隔缺损程度;评价急性冠状动脉综合征的危险分层以及预测心肌梗死的面积、病死率、致残率等方面的应用价值已日趋达成共识,其在心律失常的应用也逐渐成为研究热点,但B型利钠尿肽在心律失常中应用的相关论述较少,现就B型利钠尿肽在心律失常方面的应用进展进行综述。
With B-type natriuretic peptide in guiding the diagnosis, treatment and prognosis of heart failure; assessment of mitral stenosis, the degree of atrioventricular septal defect; assessment of risk stratification of acute coronary syndrome and prediction of myocardial infarct size, mortality , The disability and other aspects of the application value has increasingly reached a consensus that its application in the arrhythmia has gradually become a research hot spot, but B-type natriuretic peptide in the application of arrhythmia less relevant discourse, now on the B-type sodium The progress of urinary peptide in the application of arrhythmia is reviewed.